Cargando…
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
Studies on autoantibody production in patients treated with tumor necrosis factor-α (TNF-α) inhibitors reported contradictory results. We investigated in a prospective study the efficacy of a treatment with human monoclonal anti-TNF-α antibody (adalimumab) in patients with rheumatoid arthritis (RA)...
Autores principales: | Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Dell' Acqua, Donata, de Portu, Simona, Cecchini, Germana, Cruini, Carola, Carrabba, Mario, Meroni, Pier Luigi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526573/ https://www.ncbi.nlm.nih.gov/pubmed/16356192 http://dx.doi.org/10.1186/ar1851 |
Ejemplares similares
-
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
por: Capsoni, Franco, et al.
Publicado: (2005) -
Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis
por: Atzeni, Fabiola, et al.
Publicado: (2008) -
Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report
por: Talotta, Rossella, et al.
Publicado: (2016) -
Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art
por: Talotta, Rossella, et al.
Publicado: (2019) -
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)